Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

NCT00030875

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

NCT03028103

Conditions
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

NCT03886831

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSF Precision Cancer Medicine Building San Francisco, California, United States
  • Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 23 locations
View Trial Details

Related conditions